Chevy Chase Trust
ONC icon

Chevy Chase Trust’s BeOne Medicines Ltd ONC Stock Holding History

Chevy Chase Trust’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$303K Buy
+828
New +$283K ﹤0.01% 626

Other funds holding ONC

Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $73.6B AUM 18.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Chevy Chase Trust's ONC Position: Q3 2026 in Review

Chevy Chase Trust opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 828 shares worth $303K. The stake represents ﹤0.01% of the portfolio and ranks #626 among its holdings.

260 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Chevy Chase Trust held 828 shares of BeOne Medicines Ltd worth $303K as of Q3 2026.
  • BeOne Medicines Ltd was a new Chevy Chase Trust position in Q3 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Chevy Chase Trust's portfolio in Q3 2026, its #626 holding.
  • 260 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Chevy Chase Trust's 13F filing for Q3 2026, filed 13 Nov 2026.